Revenue ($USD) : $2,704,320,000
Revenue (foreign currencies) : €2,504,000,000
R&D spend : not available
Employees : 7,736
Fiscal year end : 9/30/2023
CEO : Markus Weber, Carl Zeiss Meditec president and CEO and Zeiss Medical Technology segment head

www.zeiss.com/meditec-ag/home.html

Carl Zeiss Meditec products and workflow solutions support the diagnosis and treatment of eye diseases. It also provides technology for visualizing minimally invasive surgical treatments. Carl Zeiss Meditec announced in April 2024 that it completed its $1 billion acquisition of the Dutch Ophthalmic Research Center (D.O.R.C.), which develops technology to address eye conditions such as retinal disorders, cataracts, glaucoma and refractive errors. –CN and SW

*We now count the entire Medical Technology segment at Carl Zeiss, instead of just Carl Zeiss Meditec as in previous years.